Evidence map›Paper›PMID 35949402›Full record

ArticleOpen forum infectious diseases2022

Escape of SARS-CoV-2 Variant Omicron to Mucosal Immunity in Vaccinated Subjects.

Emanuela Martinuzzi, Jacques Boutros, Nicolas Glaichenhaus, Charles Hugo Marquette, Paul Hofman, Jonathan Benzaquen

Abstract read
In one paragraph

Article in Open forum infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Observational
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Emanuela MartinuzziUniversité Côte d'Azur, CNRS, Institut de Pharmacologie Moléculaire et Cellulaire, Valbonne, France.ORCID https://orcid.org/0000-0001-5832-951X
Jacques BoutrosDepartment of Pulmonary Medicine and Thoracic Oncology, Université Côte d'Azur, Centre Hospitalier Universitaire de Nice, FHU Oncoage, Nice, France.ORCID https://orcid.org/0000-0002-6468-1648
Nicolas GlaichenhausUniversité Côte d'Azur, CNRS, Institut de Pharmacologie Moléculaire et Cellulaire, Valbonne, France.ORCID https://orcid.org/0000-0002-8997-0470
Charles Hugo MarquetteDepartment of Pulmonary Medicine and Thoracic Oncology, Université Côte d'Azur, Centre Hospitalier Universitaire de Nice, FHU Oncoage, Nice, France.ORCID https://orcid.org/0000-0002-0846-9941
Paul HofmanUniversite Cote d'Azur, CNRS, INSERM U1081, Institute of Research on Cancer and Aging, Nice, France.ORCID https://orcid.org/0000-0003-0431-9353
Jonathan BenzaquenDepartment of Pulmonary Medicine and Thoracic Oncology, Université Côte d'Azur, Centre Hospitalier Universitaire de Nice, FHU Oncoage, Nice, France.ORCID https://orcid.org/0000-0002-1899-9612

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35949402
PMCPMC9356681

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.